Cannabis Science Inc.
Cannabis Science Inc.
Cannabis Science Team
Careers & Corporate Culture
The Science of Cannabinoids
CBIS Cannabinoid Research
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
CBIS Bottle It
Products & Pharmacies
CBIS Current Share Structure
CBIS News Releases
CBIS In The News
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
: Creating default object from empty value in
Cannabis Science Identifies Another Urgent Need for Its Pharmaceutical Products as Suicides and Sudden Deaths Among Vets With Post Traumatic Stress Disorder Linked to a Number of Widely-Prescribed FDA Approved Pharmaceuticals Such as Seroquel and Other An
Cannabis Science Acquires Two Revenue Producing Operations, a Medical Marijuana Growing Facility and a Dispensary to Facilitate Operational Growth, Research and Development of Pharmaceutical Cannabis Products in Colorado in Accordance With State Laws
Cannabis Reports on Bloomberg News, 15 Members of Congress Led by Representative Barney Frank Support Dispensaries as Legitimate Businesses; Cannabis Science Value Increased for Pharmaceutical Research and Development; New Colorado Law Adds Protection
Cannabis Science President and CEO Dr. Robert Melamede, PhD., Files Preliminary Patent Disclosures With the University of Colorado Regarding New Technology That Cannabis Science Intends to Develop Through a Private Company Acquisition
Cannabis Science Anticipates Marijuana Legalization as Latest Polls Show Legalization Leading 49% in Favor With 41% Opposed; Los Angeles City Efforts to Close Medical Dispensaries Will Help Drive to End Prohibition
CBIS Announces Federal Court Order for CBIS Shares Owned by Cannex Therapeutics Controlled by Steve Kubby to be Cancelled and Re-Issued to K&D Equity Investments Inc.
Cannabis Science Jumps With Its Next Acquisition; Montana Pain Management, Inc., One of the Leading Medical Marijuana Providers in the State of Montana
Montana Governor Brian Schweitzer Visits New Cannabis Science Acquisition
Governor Schweitzer's Visit to Cannabis Science Acquisition, Montana Pain Management, Draws Extensive Media Coverage; Governor "Impressed by the Sophistication" of Operation Model for New State Regulations
Cannabis Science Reports Important Validation for Medical Cannabis as Bayer Pays '$15 Million Milestone Payment' for GW Pharmaceuticals' Sativex(R) for MS, as the UK Government Approves "First Prescription Cannabis Medicine"